Combined treatment with corticosteroids and moclobemide favors normalization of 
hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting 
multiple sclerosis: a randomized double blind trial.

Then Bergh, F.; Kümpfel, T.; Grasser, A.; Rupprecht, R.; Holsboer, F.; Trenkwalder, C.

Lokale TagsFreigabegeschichteDetailsÜbersicht

Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial.

Then Bergh, F., Kümpfel, T., Grasser, A., Rupprecht, R., Holsboer, F., & Trenkwalder, C. (2001). Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism, 86, 1610-1615.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A316-F Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A317-D

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Then Bergh, F., Autor
Kümpfel, T.¹, Autor
Grasser, A., Autor
Rupprecht, R.², Autor
Holsboer, F.³, Autor
Trenkwalder, C., Autor

Affiliations:
1Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137
2Rainer Rupprecht (Max-Planck Fellow), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607140
3Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607139